Member Info for Hurst10

Meanwhile GBP/USD will test 1.10 when US Labour numbers comes, stronger than expected and Powell have to speed up .75bp
Who is almost 100% USD earner …

Watch out, Friday volume and prices.
Peel H making 3-13
BEGO warming up, soon real price for size : 5-10
Printed sales could be something else ?

As Blackrock are buying more, we will European index /ETF funds following them and the shorts could and will be wiped out.

Worth noting that David Wilson is head of Diagnostics !

Units
Not
GBP

Last 40minutes 6 x 10/+ buy prints

The company is sitting on a pipeline of news to be released during the quarter and with Therapeutic Science day coming up as well,one would not be surprised if we have a RNS beforehand, which would make the actual Science day quite something very special and with media all over it.
Chemo without side effects! One of the biggest days in oncology and off course the Pharma majors scrambling to join at valuations not seen before.

Watch M&A picking up pace in the US as well, with Novartis and AZN making it very clear what sector they are looking at.

M&A continues to pick up pace.
Sector top performer in a nervous market

Astra Zeneca bought Logic Bio gene editing company at a 660% premium, "The proposed acquisition of LogicBio is a significant development for our growing research in genomic medicine,” said Marc Dunoyer, Chief Executive Officer, Alexion, AstraZeneca Rare Disease. “LogicBio’s people, experience and platforms provide new scientific capabilities by adding best-in-class technology and expertise to our genomic medicine strategy. The scientific collaboration between Alexion and AstraZeneca has been a substantial area of focus since last year’s acquisition and the addition of LogicBio will expand this foundational work.”

LogicBio (NASDAQ:LOGC) gained ~648% pre-market Monday after Alexion, a unit of AstraZeneca (NASDAQ:AZN) announced an agreement to acquire the U.S.-based genetic medicine company for $2.07 per share in cash.

Just a thought, but seems logical, after he was at White City office opening.

Professor Udai Banerji From Royal Marden and in charge of the hospital’s AVA6000 trials, likely to present at the Science day, with completed cohort 4 trials and congratulating them and the trials.

Arrival Produces First Production Verification Van in Micro-factory
:
London, UK (30th September, 2022) – Arrival (NASDAQ: ARVL) today announced that it has produced the first production verification vehicle from its Bicester Microfactory.
Arrival produced the first Van in a Microfactory using in-house technologies, including composite materials, autonomous mobile robots, in-house components and a software defined factory.
The milestone is a big stepping stone towards at-scale production and delivering vehicles to its customers.
“Today is an important day for Arrival. This is the first time a vehicle has ever been built in our Microfactory, using a new method that does not use a traditional assembly line. Although we have not yet achieved serial production, we are focused on making it happen. We will continue to produce vehicles in our Microfactory in order to master at-scale production,” said Denis Sverdlov, Founder and CEO at Arrival.

Back AM NY trading:
We have the usual pair on bid/offer
Lots of 10/ prints going through and you will find the cheap offer moving across and it will be 108-12
Early coffee’s being served over there, stand by for bids coming through!

30/ buys being printed continuously

Now, we have BEGO back on the bid and offer price going north.
Good morning NY

Novartis been to all the conferences !

One or two MM were just enjoying themselves earlier in the day picking up stock 96 -9, before marking it up to 113!

Try and buy 50/+ and you will pay 116+

Watch out for the buy order print, picking up those so called selling orders!!